References
- PicciPOsteosarcoma: What did we learn from the paediatric experience for adolescents and young adults?European Journal of Cancer Supplements200755227234
- SweetnamROsteosarcomaBr J Hosp Med19822821121161216957252
- DorfmanHDCzerniakBBone cancersCancer1995751 Suppl2032108000997
- OttavianiGJaffeNThe epidemiology of osteosarcomaCancer Treat Res200915231320213383
- MirabelloLTroisiRJSavageSAOsteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results ProgramCancer200911571531154319197972
- WangLLBiology of osteogenic sarcomaCancer J200511429430516197719
- EkETOjaimiJKitagawaYChoongPFOutcome of patients with osteosarcoma over 40 years of age: is angiogenesis a marker of survival?Int Semin Surg Oncol20063716551370
- HuvosAGOsteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 yearsCancer1986577144214492418941
- MeyersPASchwartzCLKrailoMDOsteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival – a report from the Children’s Oncology GroupJ Clin Oncol200826463363818235123
- DamronTAWardWGStewartAOsteosarcoma, chondrosarcoma, and Ewing’s sarcoma: National Cancer Data Base ReportClin Orthop Relat Res2007459404717414166
- KagerLZoubekAPötschgerUPrimary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocolsJ Clin Oncol200321102011201812743156
- MintzMBSowersRBrownKMAn expression signature classifies chemotherapy-resistant pediatric osteosarcomaCancer Res2005655651754
- Endo-MunozLCummingASommervilleSDickinsonISaundersNAOsteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal boneBr J Cancer20101031738120551950
- HaydonRCZhouLFengTNuclear receptor agonists as potential differentiation therapy agents for human osteosarcomaClin Cancer Res2002851288129412006550
- ChouAJGorlickRChemotherapy resistance in osteosarcoma: current challenges and future directionsExpert Rev Anticancer Ther2006671075108516831079
- ClarkJCDassCRChoongPFA review of clinical and molecular prognostic factors in osteosarcomaJ Cancer Res Clin Oncol2008134328129717965883
- JanewayKAGrierHESequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effectsLancet Oncol201017670678
- WozneyJMRosenVCelesteAJNovel regulators of bone formation: molecular clones and activitiesScience19882424885152815343201241
- ChenGDengCLiYPYpLTGF-β and BMP signaling in osteoblast differentiation and bone formationInt J Biol Sci20128227228822298955
- YeLMasonMDJiangWGBone morphogenetic protein and bone metastasis, implication and therapeutic potentialFront Biosci201116865
- HruskaKAMathewSSaabGBone morphogenetic proteins in vascular calcificationCirc Res200597210511416037577
- HoganBLBone morphogenetic proteins: multifunctional regulators of vertebrate developmentGenes Dev19961013158015948682290
- BarbozaECaúlaAMachadoFPotential of recombinant human bone morphogenetic protein-2 in bone regenerationImplant Dent19998436036710709481
- ThawaniJPWangACThanKDLinCYLa MarcaFParkPBone morphogenetic proteins and cancer: review of the literatureNeurosurgery201066223324620042986
- KleeffJMaruyamaHIshiwataTBone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivoGastroenterology199911651202121610220513
- LangenfeldEMCalvanoSEAbou-NuktaFLowrySFAmentaPLangenfeldJThe mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cellsCarcinogenesis20032491445145412819188
- Ghosh-ChoudhuryNWoodruffKQiWCelesteAAbboudSLGhosh ChoudhuryGBone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylationBiochem Biophys Res Commun2000272370571110860819
- Ghosh-ChoudhuryNGhosh-ChoudhuryGCelesteABone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cellsBiochim Biophys Acta20001497218619610903423
- KawamuraCKizakiMYamatoKBone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3Blood20009662005201110979940
- WenXZMiyakeSAkiyamaYYuasaYBMP-2 modulates the proliferation and differentiation of normal and cancerous gastric cellsBiochem Biophys Res Commun2004316110010615003517
- BeckSEJungBHFiorinoABone morphogenetic protein signaling and growth suppression in colon cancerAm J Physiol Gastrointest Liver Physiol20062911G135G14516769811
- PiccirilloSGReynoldsBAZanettiNBone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cellsNature2006444712076176517151667
- IdeHYoshidaTMatsumotoNGrowth regulation of human prostate cancer cells by bone morphogenetic protein-2Cancer Res19975722502250279371496
- BrubakerKDCoreyEBrownLGVessellaRLBone morphogenetic protein signaling in prostate cancer cell linesJ Cell Biochem200491115116014689587
- HuangWRudkinGHCarlsenBOverexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cellsExp Cell Res2002274222623411900483
- GengSSunBLuRWangJColeusin factor, a novel anticancer diterpenoid, inhibits osteosarcoma growth by inducing bone morphogenetic protein-2-dependent differentiationMol Cancer Ther20141361431144124723453
- WangLParkPZhangHBMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell lineCancer Biol Ther201111545746321178508
- WangLParkPZhangHBMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formationInt J Cancer201213181941195022275155
- GellerDSSinghMYZhangWDevelopment of a model system to evaluate local recurrence in osteosarcoma and assessment of the effects of bone morphogenetic protein-2Clin Cancer Res201521133003301225472999
- GillJConnollyPRothMThe effect of bone morphogenetic protein-2 on osteosarcoma metastasisPLoS One2017123e017332228264040
- YuZSunHFanQLongHYangTMaBEstablishment of reproducible osteosarcoma rat model using orthotopic implantation techniqueOncol Rep20092151175118019360291
- WangLParkPZhangHLa MarcaFLinCYProspective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activityInt J Cancer2011128229430320309879
- WangLParkPLinCYCharacterization of stem cell attributes in human osteosarcoma cell linesCancer Biol Ther20098654355219242128
- GattaGCapocacciaRStillerCChildhood cancer survival trends in Europe: a EUROCARE Working Group studyJ Clin Oncol200523163742375115923571
- ShimizuTFuchimotoYFukudaKOkitaHKitagawaYKurodaTThe effect of immune checkpoint inhibitors on lung metastases of osteosarcomaJ Pediatr Surg201752122047205028954696
- SarafAJFengerJMRobertsRDOsteosarcoma: Accelerating Progress Makes for a Hopeful FutureFront Oncol20188429435436
- TiekenCVerboomMCRufWTissue factor associates with survival and regulates tumour progression in osteosarcomaThromb Haemost201611551025103326763081
- HeatonTEDavidoffAMSurgical treatment of pulmonary metastases in pediatric solid tumorsSemin Pediatr Surg201625531131727955735
- PardalRClarkeMFMorrisonSJApplying the principles of stem-cell biology to cancerNat Rev Cancer200331289590214737120
- JordanCTGuzmanMLNobleMCancer stem cellsN Engl J Med2006355121253126116990388
- ClarkeMFDickJEDirksPBCancer stem cells – perspectives on current status and future directions: AACR Workshop on cancer stem cellsCancer Res200666199339934416990346
- DeanMFojoTBatesSTumour stem cells and drug resistanceNat Rev Cancer20055427528415803154
- Basu-RoyUBasilicoCMansukhaniAPerspectives on cancer stem cells in osteosarcomaCancer Lett2013338115816722659734
- AbarrategiATorninJMartinez-CruzadoLOsteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesStem Cells Int201620161313
- SellSStem cell origin of cancer and differentiation therapyCrit Rev Oncol Hematol200451112815207251
- SellSCancer stem cells and differentiation therapyTumour Biol2006272597016557043
- AbdullahLNChowEKMechanisms of chemoresistance in cancer stem cellsClin Transl Med2013213323369605
- MassardCDeutschESoriaJCTumour stem cell-targeted treatment: elimination or differentiationAnn Oncol200617111620162416600978
- AguadoTCarracedoAJulienBCannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesisJ Biol Chem200728296854686217202146
- YanMLiuQDifferentiation therapy: a promising strategy for cancer treatmentChin J Cancer201635326739838
- JinXJinXKimHCancer stem cells and differentiation therapyTumour Biol20173910101042831772993329072131
- YanMZhangYHeBIKKα restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiationNat Commun20145366124739462
- MurakamiSNinomiyaWSakamotoEShibataTAkiyamaHTashiroFSRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy TargetsStem Cells20153392652266326013162
- ZhangLSunHZhaoFBMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinomaCancer Res201272164276428522773665
- CamposBWanFFarhadiMDifferentiation therapy exerts antitumor effects on stem-like glioma cellsClin Cancer Res201016102715272820442299
- YanYLiZXuXAll-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapyBMC Complement Altern Med20161611327036550
- WangLParkPLa MarcaFThanKRahmanSLinCYBone formation induced by BMP-2 in human osteosarcoma cellsInt J Oncol20134341095110223900689
- WangLParkPLa MarcaFThanKDLinCYBMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formationJ Cancer Res Clin Oncol201514161013102425431339